|TRPX -- Israel Stock|| |
null 33.70 0.70 2.12%
Therapix Biosciences Ltd diagnostics interface makes it easy to digest most current publicly released information about Therapix Biosciences as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Therapix Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.
Therapix Biosciences Note
The company recorded loss per share of 0.04. Therapix Biosciences Ltd had not issued any dividends in recent years. This company had a split on 2014-01-12. Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel. Therapix Biosciences operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 9 people. To find out more about THERAPIX BIO contact Ascher Shmulewitz at 972 3 616 7055 or learn more at http://www.therapixbio.com.
Therapix Biosciences Alerts
|Therapix Biosciences is not yet fully synchronised with the market data|
|Therapix Biosciences has high likelihood to experience some financial distress in the next 2 years|
|The company reported revenue of . Net Loss for the year was (7.66M). |
|THERAPIX BIO has accumulated about 7.51M in cash with (6.01M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. |
The company currently falls under 'Micro-Cap' category with current market capitalization of 44.76M.
Therapix Biosciences Ltd has return on total asset (ROA) of (37.65) %
which means that it has lost $37.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (216.64) %
meaning that it generated substantial loss on money invested by shareholders.
Therapix Biosciences Technical and Predictive Indicators